EVALUATION OF TOLERABILITY AND ANTI-TUMOR ACTIVITY OF GDC-0980, AN ORAL PI3K/MTOR INHIBITOR, ADMINISTERED TO PATIENTS WITH ADVANCED MALIGNANT PLEURAL MESOTHELIOMA (MPM)Saoirse O. Dolly,Lee M. Krug,Andrew J. Wagner,Lawrence H. Schwartz,Johanna C. Bendell,Jennifer O. Lauchle,Tanguy Y. Seiwert,Karim Rihawi,Nina Tunariu,Marjorie G. Zauderer,Lukas Delasos,David Kwiatkowski,J. P. Marcoux,Michael S. Rabin,Doris Apt,Jill Fredrickson,Mark Lackner,Hartmut Koeppen,Joseph A. Ware,Howard A. Burris,Johann S. De Bono,Hedy KindlerJOURNAL OF THORACIC ONCOLOGY（2013）引用 0|浏览26暂无评分关键词PI3K,GDC-0980,MPM,mTORAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
